The ins and outs of SARS-CoV-2 variants of concern (VOCs)

被引:35
作者
Salehi-Vaziri, Mostafa [1 ,2 ,3 ]
Fazlalipour, Mehdi [1 ]
Seyed Khorrami, Seyed Mahmood [4 ]
Azadmanesh, Kayhan [3 ,5 ]
Pouriayevali, Mohammad Hassan [1 ,2 ]
Jalali, Tahmineh [1 ,2 ]
Shoja, Zabihollah [5 ]
Maleki, Ali [1 ,5 ]
机构
[1] Pasteur Inst Iran, COVID Natl Reference Lab 19, 69 Pasteur Ave, Tehran 1316943551, Iran
[2] Pasteur Inst Iran, Dept Arboviruses & Viral Hemorrhag Fevers, Natl Reference Lab, Tehran, Iran
[3] Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Tehran, Iran
[4] Tarbiat Modares Univ, Dept Virol, Fac Med Sci, Tehran, Iran
[5] Pasteur Inst Iran, Dept Mol Virol, Tehran, Iran
关键词
RECEPTOR-BINDING DOMAIN; MUTATIONS; COVID-19; B.1.1.7; RISK; VACCINE;
D O I
10.1007/s00705-022-05365-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
SARS-CoV-2, a newly emerging coronavirus that caused the COVID-19 epidemic, has been spreading quickly throughout the world. Despite immunization and some fairly effective therapeutic regimens, SARS-CoV-2 has been ravaging patients, health workers, and the economy. SARS-CoV-2 mutates and evolves to adapt to its host as a result of extreme selection pressure. As a consequence, new SARS-CoV-2 variants have emerged, some of which are classified as variants of concern (VOC) because they exhibit greater transmissibility, cause more-severe disease, are better able to escape immunity, or cause higher mortality than the original Wuhan strain. Here, we introduce these VOCs and review their characteristics, such as transmissibility, immune escape, mortality risk, and diagnostics.
引用
收藏
页码:327 / 344
页数:18
相关论文
共 146 条
  • [1] New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications
    Abdool Karim, Salim S.
    de Oliveira, Tulio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (19) : 1866 - 1868
  • [2] Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Butt, Adeel A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02) : 187 - 189
  • [3] Aldridge Robert W, 2020, Wellcome Open Res, V5, P52, DOI 10.12688/wellcomeopenres.15812.1
  • [4] American Society of Anesthesiologists, COVID-19 guidelines, coronavirus (2019- nCoV) COVID-19
  • [5] SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
    Andreano, Emanuele
    Piccini, Giulia
    Licastro, Danilo
    Casalino, Lorenzo
    Johnson, Nicole, V
    Paciello, Ida
    Dal Monego, Simeone
    Pantano, Elisa
    Manganaro, Noemi
    Manenti, Alessandro
    Manna, Rachele
    Casa, Elisa
    Hyseni, Inesa
    Benincasa, Linda
    Montomoli, Emanuele
    Amaro, Rommie E.
    McLellan, Jason S.
    Rappuoli, Rino
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (36)
  • [6] Andrew Rambaut NL, PRELIMINARY GENOMIC
  • [7] [Anonymous], 2020, Virological
  • [8] [Anonymous], 2021, Weekly epidemiological update on COVID-19-20 April 2021, V46th
  • [9] Could mutations of SARS-CoV-2 suppress diagnostic detection?
    Ascoli, Carl A.
    [J]. NATURE BIOTECHNOLOGY, 2021, 39 (03) : 274 - +
  • [10] Banati P, 2021, SUSTAINABLE HUMAN DEVELOPMENT ACROSS THE LIFE COURSE, P1, DOI 10.1101/2021.03.05.21252709